199 related articles for article (PubMed ID: 36569137)
21. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
[TBL] [Abstract][Full Text] [Related]
22. Hepatic immunohistochemistry of bile transporters in progressive familial intrahepatic cholestasis.
El-Guindi MA; Sira MM; Hussein MH; Ehsan NA; Elsheikh NM
Ann Hepatol; 2016; 15(2):222-9. PubMed ID: 26845599
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
Gordo-Gilart R; Andueza S; Hierro L; Martínez-Fernández P; D'Agostino D; Jara P; Alvarez L
Gut; 2015 Jan; 64(1):147-55. PubMed ID: 24594635
[TBL] [Abstract][Full Text] [Related]
24. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Reichert MC; Lammert F
Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767
[TBL] [Abstract][Full Text] [Related]
25. A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis.
Küçükçongar Yavaş A; Çavdarlı B; Ünal Uzun Ö; Uncuoğlu A; Gündüz M
J Pediatr Endocrinol Metab; 2020 May; 33(5):665-669. PubMed ID: 32229667
[TBL] [Abstract][Full Text] [Related]
26. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
[TBL] [Abstract][Full Text] [Related]
27. Dietary lecithin protects against cholestatic liver disease in cholic acid-fed Abcb4- deficient mice.
Lamireau T; Bouchard G; Yousef IM; Clouzeau-Girard H; Rosenbaum J; Desmoulière A; Tuchweber B
Pediatr Res; 2007 Feb; 61(2):185-90. PubMed ID: 17237720
[TBL] [Abstract][Full Text] [Related]
28. ABCB4 disease: Many faces of one gene deficiency.
Sticova E; Jirsa M
Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
[TBL] [Abstract][Full Text] [Related]
29. A novel compound heterozygous mutation in ABCB4 gene in a pedigree with progressive familial intrahepatic cholestasis 3: a case report.
Bai J; Li L; Liu H; Liu S; Bai L; Ning H; Song W; Zou H; Wang X; Chen Y; Zheng S; Duan Z
Ann Transl Med; 2021 Mar; 9(5):426. PubMed ID: 33842647
[TBL] [Abstract][Full Text] [Related]
30. Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis.
Kunne C; de Graaff M; Duijst S; de Waart DR; Oude Elferink RP; Paulusma CC
Lab Invest; 2014 Oct; 94(10):1103-13. PubMed ID: 25068656
[TBL] [Abstract][Full Text] [Related]
31. ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations Associated with Cholestasis with Different Phenotypes and Outcomes.
Al-Hussaini A; Lone K; Bashir MS; Alrashidi S; Fagih M; Alanazi A; AlYaseen S; Almayouf A; Alruwaithi M; Asery A
J Pediatr; 2021 Sep; 236():113-123.e2. PubMed ID: 33915153
[TBL] [Abstract][Full Text] [Related]
32. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
[TBL] [Abstract][Full Text] [Related]
33. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
Semin Liver Dis; 2010 May; 30(2):134-46. PubMed ID: 20422496
[TBL] [Abstract][Full Text] [Related]
34. Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.
Ben Saad A; Vauthier V; Tóth Á; Janaszkiewicz A; Durand-Schneider AM; Bruneau A; Delaunay JL; Lapalus M; Mareux E; Garcin I; Gonzales E; Housset C; Aït-Slimane T; Jacquemin E; Di Meo F; Falguières T
Liver Int; 2021 Jun; 41(6):1344-1357. PubMed ID: 33650203
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of exons 6, 8 and 9 of ABCB4 gene in children with Progressive Familial Intrahepatic Cholestasis type 3.
Fathy M; Kamal M; Al-Sharkawy M; Al-Karaksy H; Hassan N
Biomarkers; 2016 Nov; 21(7):573-7. PubMed ID: 27075526
[TBL] [Abstract][Full Text] [Related]
36. A novel heterozygous deletion in ABCB4 gene in a Chinese family with intrahepatic cholestasis of pregnancy, neonatal hyperbilirubinemia, and cholelithiasis: Case reports and literature review.
Zheng Y; Rao Q; Han Y; He J
Mol Genet Genomic Med; 2024 Jan; 12(1):e2291. PubMed ID: 37787087
[TBL] [Abstract][Full Text] [Related]
37. ABCB4 Mutations in Adults Cause a Spectrum Cholestatic Disorder Histologically Distinct from Other Biliary Disease.
Sinha A; Bhuva M; Grant C; Gimson AE; Thompson E; Duckworth A; Davies SE; Aithal G; Griffiths WJ
Dig Dis Sci; 2022 Dec; 67(12):5551-5561. PubMed ID: 35288833
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis of progressive familial intrahepatic cholestasis 3. A proteomics study.
Guerrero L; Carmona-Rodríguez L; Santos FM; Ciordia S; Stark L; Hierro L; Pérez-Montero P; Vicent D; Corrales FJ
Biofactors; 2024 Jan; ():. PubMed ID: 38284625
[TBL] [Abstract][Full Text] [Related]
39. Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in
Wang R; Sheps JA; Liu L; Han J; Chen PSK; Lamontagne J; Wilson PD; Welch I; Borchers CH; Ling V
J Lipid Res; 2019 Jan; 60(1):85-97. PubMed ID: 30416103
[TBL] [Abstract][Full Text] [Related]
40. Chinese children with chronic intrahepatic cholestasis and high γ-glutamyl transpeptidase: clinical features and association with ABCB4 mutations.
Fang LJ; Wang XH; Knisely AS; Yu H; Lu Y; Liu LY; Wang JS
J Pediatr Gastroenterol Nutr; 2012 Aug; 55(2):150-6. PubMed ID: 22343912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
